Ledger.Open graph →
SEC Form D · Amendment · filed November 12, 2025

ZETAGEN THERAPEUTICS, INC

Offering
$13.0M
Sold
$12.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SYRACUSE, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Peter B. Finn · Boston, MAExecJoshua Resnick · Boston, MAExec · DirectorNikhil Thakur, Md · Andover, MAExec · DirectorSteven Sordello · New York, NYDirectorSteve Wolin · Minneapolis, MNDirectorDonald C. Brown · Hopkinton, MADirectorMichael J. Stark · Menlo Park, CADirectorJoe C. Loy · Weatherford, TXExec · DirectorHans Miller · Arlington, VAExecWilliam O. White · Baltimore, MDDirectorTodd Crow · Portland, ORDirectorGregory M. Gentile · New York, NYExec · DirectorRichard C. Warburg · Bethesda, MDDirectorRobert Poulin · Arlington, VAExec · DirectorAndrew Levin · Boston, MAExecNicholas Bienstock · New York, NYExec · DirectorAshok C. Kaveeshwar · Bethesda, MDDirectorMichael D. Hankin · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗